University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Foundation for Innovative New Diagnostics (FIND), University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Fred Hutchinson Cancer Research Center, Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, London School of Hygiene & Tropical Medicine, London School of Hygiene & Tropical Medicine, The Aurum Institute, Aurum Institute for Health Research, Stellenbosch University, Stellenbosch University, Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Stellenbosch University - Division of Molecular Biology and Human Genetics, University of KwaZulu-Natal - Centre for the AIDS Programme of Research in South Africa (CAPRISA)University of the Witwatersrand - South African Medical Research Council, Aurum Institute, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative and Independent